Inhaled Treatment Reduces Severe COVID-19 Risk by 79 Percent
Inhaled Treatment Reduces Severe COVID-19 Risk by 79 Percent
Labiotech.eu—Senior Investigator Warner Greene, MD, PhD, comments on the use of interferons as therapeutic intervention in the early stages of COVID-19.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab